Monjuvi Injection, Powder, Lyophilized, For Solution
Product Images NDC 73535-208

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Monjuvi (NDC 73535-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Incyte Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

This is a medication called "MONJUVI" (tafasitamab-cxix) which is used for intravenous infusion only. Each single-dose vial contains 200 mg of the medication and must be reconstituted and diluted prior to administration. The vial must be discarded if unused. It should be refrigerated and protected from light. This medicine is manufactured by MorphoSys US Inc. and marketed by MorphoSys US Inc. and Incyte Corp. For more information on dosage and storage, refer to the prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.